Resource Type
Factsheet
Poster
Audience
Health Professionals
Health Topic
Immunizations
Attachments
Description
The documents above detail instructions and indications to Health Care Providers regarding Pneumococcal Vaccine.
Ontario’s publicly funded pneumococcal vaccine program is transitioning to the following new pneumococcal vaccines:
- Pneumococcal 15-valent conjugate (Pneu-C-15), Vaxneuvance
- Pneumococcal 20-valent conjugate (Pneu-C-20), Prevnar 20
These two new pneumococcal conjugate vaccines will provide broader protection against invasive pneumococcal disease (IPD) compared to Pneu-C-13 and longer-term protection than Pneu-P-23, which are currently used in the provincial program.
Please refer to the PDF documents above for additional information (French versions are also included):
- Health Care Provider Fact Sheet: Pneumococcal Conjugate Vaccines for Children Aged 6 Weeks to 4 Years
- Health Care Provider Fact Sheet: Pneumococcal Conjugate Vaccine for High-Risk Individuals Aged 5 to 64 Years
- Health Care Provider Fact Sheet: Pneumococcal Conjugate Vaccine for Individuals Aged 65 Years and Older
- Vaccine Fact Sheet: Pneumococcal Vaccine Program for Individuals Aged 6 Weeks and Older
- Qs & As for Health Care Providers: Pneumococcal Vaccine Transition
The program transition is planned for July 29, 2024.